Using drugs safely in chronic kidney disease

M. Kirby

doi:10.3132/pccj.2011.040

Using drugs safely in chronic kidney disease

M. Kirby

Public Involvement and Engagement in Health and Care

Research output: Contribution to journal › Book/Film/Article review › peer-review

Abstract

Chronic kidney disease (CKD) affects renal drug elimination and other important processes involved in drug disposition, including absorption, drug distribution and non-renal clearance. As a result, the reduced renal excretion of a drug or its metabolites can cause toxicity and the sensitivity to some drugs is increased even if elimination is unimpaired.

Original language	English
Pages (from-to)	17-20
Number of pages	4
Journal	Primary Care Cardiovascular Journal
Volume	4
Issue number	SPEC. ISSUE
DOIs	https://doi.org/10.3132/pccj.2011.040
Publication status	Published - 2011

Access to Document

10.3132/pccj.2011.040

Cite this

@article{290b92f2ee574e97a146b58715e3933a,

title = "Using drugs safely in chronic kidney disease",

abstract = "Chronic kidney disease (CKD) affects renal drug elimination and other important processes involved in drug disposition, including absorption, drug distribution and non-renal clearance. As a result, the reduced renal excretion of a drug or its metabolites can cause toxicity and the sensitivity to some drugs is increased even if elimination is unimpaired.",

author = "M. Kirby",

note = "Original review can be found at: http://www.pccj.eu/ Copyright the journal [Full text of this review is not available in the UHRA]",

year = "2011",

doi = "10.3132/pccj.2011.040",

language = "English",

volume = "4",

pages = "17--20",

journal = "Primary Care Cardiovascular Journal",

issn = "1756-5138",

publisher = "Sherborne Gibbs Limited",

number = "SPEC. ISSUE",

}

TY - JOUR

T1 - Using drugs safely in chronic kidney disease

AU - Kirby, M.

N1 - Original review can be found at: http://www.pccj.eu/ Copyright the journal [Full text of this review is not available in the UHRA]

PY - 2011

Y1 - 2011

N2 - Chronic kidney disease (CKD) affects renal drug elimination and other important processes involved in drug disposition, including absorption, drug distribution and non-renal clearance. As a result, the reduced renal excretion of a drug or its metabolites can cause toxicity and the sensitivity to some drugs is increased even if elimination is unimpaired.

AB - Chronic kidney disease (CKD) affects renal drug elimination and other important processes involved in drug disposition, including absorption, drug distribution and non-renal clearance. As a result, the reduced renal excretion of a drug or its metabolites can cause toxicity and the sensitivity to some drugs is increased even if elimination is unimpaired.

UR - https://www.scopus.com/pages/publications/80052935539

U2 - 10.3132/pccj.2011.040

DO - 10.3132/pccj.2011.040

M3 - Book/Film/Article review

AN - SCOPUS:80052935539

SN - 1756-5138

VL - 4

SP - 17

EP - 20

JO - Primary Care Cardiovascular Journal

JF - Primary Care Cardiovascular Journal

IS - SPEC. ISSUE

ER -

Using drugs safely in chronic kidney disease

Abstract

Access to Document

Other files and links

Fingerprint

Cite this